S
Sonali B. Fonseca
Researcher at University of Toronto
Publications - 10
Citations - 1383
Sonali B. Fonseca is an academic researcher from University of Toronto. The author has contributed to research in topics: Mitochondrion & Chlorambucil. The author has an hindex of 9, co-authored 10 publications receiving 1242 citations.
Papers
More filters
Journal ArticleDOI
Recent advances in the use of cell-penetrating peptides for medical and biological applications.
TL;DR: This review describes recent advances in the use of CPPs for biological and therapeutic applications and describes the remarkable advancements these peptides have facilitated in cell biology.
Journal ArticleDOI
Mitochondria-Penetrating Peptides
TL;DR: A significant advance is reported in the development of mitochondrial transporters-synthetic cell-permeable peptides that are able to enter mitochondria and demonstrate that mitochondrial localization can be rationally controlled and finely tuned by altering lipophilicity and charge.
Journal ArticleDOI
Potential Use of Cetrimonium Bromide as an Apoptosis-Promoting Anticancer Agent for Head and Neck Cancer
Emma Ito,Kenneth W. Yip,David F. Katz,Sonali B. Fonseca,David W. Hedley,Sue Chow,G. Wei Xu,Tabitha E. Wood,Carlo Bastianutto,Aaron D. Schimmer,Shana O. Kelley,Fei-Fei Liu +11 more
TL;DR: CTAB was identified as a potential apoptogenic quaternary ammonium compound possessing in vitro and in vivo efficacy against HNC models, and exhibited anticancer cytotoxicity against several HNC cell lines, with minimal effects on normal fibroblasts.
Journal ArticleDOI
The antiparasitic agent ivermectin induces chloride-dependent membrane hyperpolarization and cell death in leukemia cells.
Sumaiya Sharmeen,Marko Skrtic,Mahadeo A. Sukhai,Rose Hurren,Marcela Gronda,Xiaoming Wang,Sonali B. Fonseca,Hong Sun,Tabitha E. Wood,Tabitha E. Wood,Richard Ward,Mark D. Minden,Robert A. Batey,Alessandro Datti,Alessandro Datti,Jeff Wrana,Shana O. Kelley,Aaron D. Schimmer +17 more
TL;DR: iptin, a derivative of avermectin B1 that is licensed for the treatment of the parasitic infections, strongyloidiasis and onchocerciasis, but is also effective against other worm infestations, could be rapidly advanced into clinical trial for leukemia.
Journal ArticleDOI
Rerouting chlorambucil to mitochondria combats drug deactivation and resistance in cancer cells
Sonali B. Fonseca,Mark P. Pereira,Rida Mourtada,Marcela Gronda,Kristin L. Horton,Rose Hurren,Mark D. Minden,Aaron D. Schimmer,Shana O. Kelley +8 more
TL;DR: This work reports the first successful delivery of an active DNA alkylating agent--chlorambucil--to mitochondria, and describes unexpected features that result from rerouting this drug within the cell.